Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

Other companies are reporting weakness in China and I see this as a risk for Haleon too. For now, though, there is no sign of that happening: last year saw mid-single digit growth in China ...

Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.

As a hybrid healthcare and consumer staple stock, Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth. Room for expanding ...

Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on ...

Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...

Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock ...

Haleon plc (LSE/NYSE: HLN), a leading global consumer health company with a market capitalization of $45.7 billion, announced today that as of March 31, 2025, the total number of issued shares ...

Haleon is to axe diversity targets from its executive bonus scheme in the latest sign that UK businesses are rowing back on DEI. The Sensodyne-maker has confirmed that its chief executive and ...